Skip to main content

somatropin

Generic: somatropin·Brand: Norditropin

somatropin: 12 clinical trials tracked.

somatropin evidence translation

What we can confirm

12 tracked trials

No verified listed developer

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about somatropin, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence5 indications · 5 study sponsors
Clinical Trials (12)showing 10 most recent

CSP #2018 - Growth Hormone Replacement Therapy in Veterans With Mild Traumatic Brain Injury (mTBI) and Adult Growth Hormone Deficiency (AGHD)

NCT04867317·Phase 3·GHRS
Recruiting

Primary endpoint: QoL-AGHDA (Quality of Life-Assessment of Adult Growth Hormone in Adults)

InterventionalRandomizedquadruple172 targetStarted 2025-01Completion 2029-0916 sites · United StatesVA Office of Research and Development

New InsiGHTS: A Multicenter, Phase 2, Randomized, Open-label, Active-controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability, and Efficacy of Different Dose Levels of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Individuals With Turner Syndrome

NCT05690386·Phase 2·ASND
Active, not recruiting

Primary endpoint: Annualized Height Velocity (AHV) (cm/year)

InterventionalRandomizedopen48 targetStarted 2023-02Completion 2027-1219 sites · United StatesAscendis Pharma Endocrinology Division A/S

Growth Hormone in a Patient With a Dominant-Negative GHR Mutation

NCT05382637·Phase 2

Primary endpoint: Growth Hormone Dose

Interventionalopen1 targetStarted 2022-08Completion 2028-091 site · United StatesChildren's National Research Institute

A Study Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® as Well as Evaluating Long-term Safety of Somapacitan in a Basket Study Design in Children With Short Stature Either Born Small for Gestational Age or With Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature

NCT05330325·Phase 3·NVO
Active, not recruiting

Primary endpoint: Height velocity reported separately for small for gestational age (SGA), Turner syndrome (TS), Noonan syndrome (NS) and idiopathic short stature (ISS)

InterventionalRandomizedopen412 targetStarted 2022-08Completion 2027-1050 sites · Austria, Belgium, Brazil, Bulgaria…Novo Nordisk A/S

French Registry of Children Treated With Norditropin® for Short Stature Associated With Noonan Syndrome

NCT05308927·NVO
Enrolling by invitation

Primary endpoint: Change in height standard deviation score

Observational221 targetStarted 2022-03Completion 2028-033 sites · FranceNovo Nordisk A/S

A Trial Comparing the Efficacy and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® in Chinese Children With Growth Hormone Deficiency

NCT04970654·Phase 3·NVO
Completed

Primary endpoint: Height Velocity

InterventionalRandomizedopen110 enrolledStarted 2021-07Completion 2023-1232 sites · ChinaNovo Nordisk A/S

foresiGHt: A Multicenter, Randomized, Parallel-arm, Placebo-controlled (Double- Blind) and Active-controlled (Open-label) Trial to Compare the Efficacy and Safety of Once-weekly Lonapegsomatropin With Placebo and a Daily Somatropin Product in Adults With Growth Hormone Deficiency

NCT04615273·Phase 3·ASND
Completed

Primary endpoint: Change From Baseline in Trunk Percent Fat at Week 38

InterventionalRandomizeddouble264 enrolledStarted 2020-12Completion 2023-1250 sites · Armenia, Australia, Canada, Denmark…Ascendis Pharma Endocrinology Division A/S

Recombinant Human Growth Hormone (GH): Effects on Metabolic Profile, Body Composition and Skeletal Muscle Strength and Function in Pre-pubertal Short Boys With and Without GH Deficiency

NCT04020913
Completed

Primary endpoint: Skeletal muscle strength (Newtons)

Observational45 enrolledStarted 2019-07Completion 2025-101 site · United StatesNemours Children's Clinic

A Dose-finding Trial Evaluating the Effect and Safety of Once-weekly Treatment of Somapacitan Compared to Daily Norditropin® in Children With Short Stature Born Small for Gestational Age With no Catch-up Growth by 2 Years of Age or Older

NCT03878446·Phase 2·NVO
Active, not recruiting

Primary endpoint: Height Velocity

InterventionalRandomizedopen62 enrolledStarted 2019-07Completion 2026-1250 sites · Algeria, Austria, Canada, Denmark…Novo Nordisk A/S

A Trial Comparing the Effect and Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® in Children With Growth Hormone Deficiency

NCT03811535·Phase 3·NVO
Completed

Primary endpoint: Height Velocity: In-trial Observation Period

InterventionalRandomizedopen200 enrolledStarted 2019-05Completion 2025-0950 sites · Algeria, Austria, Canada, Denmark…Novo Nordisk A/S